Alzheimers 2019 objective is to bring all existing and budding bio entrepreneurs together to share present and experiences new challenges and innovations in Alzheimers & Dementia community. Every year, over a million companies are started in the world with about 5–10 of them known as high technology companies. Changing ideas into business ventures is tricky opportunity-recognition step critical in new venture creation. Even though life scientists are the founders of biotech companies, studies have shown that most successful high tech start-ups are founded by a team of two to three individuals with mixed backgrounds, substantial industry experience and a very clear market and product focus at founding. This two days conference will be a highly interactive forum that will bring experts in areas ranging from Alzheimer's disease analysis to novel therapeutic techniques and approaches to cure Alzheimer disease. Our outstanding speakers will do talks for 25-30 min and Students do poster presentations from submitted abstracts. Interested business candidates will exhibit their products and some do Workshops.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
